Anemia in renal disease: diagnosis and management.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.blre.2009.09.001PMID 19833421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation.

  2009cited by this paper
• Iron and clinical outcomes in dialysis and non-dialysis-dependent chronic kidney disease patients.

  2009cited by this paper
• Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.

  2009cited by this paper
• Hepcidin assays: ironing out some details.

  2009cited by this paper
• Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease.

  2009cited by this paper
• What is so bad about a hemoglobin level of 12 to 13 g/dL for chronic kidney disease patients anyway?

  2009cited by this paper
• Healthcare Expenditure and Resource Utilization in Patients with Anaemia and Chronic Kidney Disease: A Retrospective Claims Database Analysis

  2009cited by this paper
• Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease.

  2008cited by this paper
• The Economic Impact of Pre-Dialysis Epoetin Alfa on Health Care and Work Loss Costs in Chronic Kidney Disease: An Employer's Perspective

  2008cited by this paper
• Ferumoxytol for treating iron deficiency anemia in CKD.

  2008cited by this paper
• Beneficial Hematologic Effects of Daily Oral Ascorbic Acid Therapy in ESRD Patients with Anemia and Abnormal Iron Homeostasis: A Preliminary Study

  2008cited by this paper
• Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

  2008cited by this paper
• Immunoassay for human serum hepcidin.

  2008cited by this paper
• Iron‐depletion limits intracellular bacterial growth in macrophages

  2008cited by this paper
• An Examination of Productivity and Resource Utilization Associated With Epoetin Alfa Treatment in Employees With Predialysis Chronic Kidney Disease

  2008cited by this paper
• New agents that stimulate erythropoiesis.

  2007cited by this paper
• Pharmacoeconomics: Effect of Erythropoiesis-Stimulating Agents on Healthcare Utilization, Costs, and Outcomes in Chronic Kidney Disease

  2007cited by this paper
• Pharmacology of darbepoetin alfa.

  2007cited by this paper
• HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Intravenous Iron Therapy in End‐Stage Renal Disease

  2006cited by this paper
• Correction of anemia with epoetin alfa in chronic kidney disease.

  2006cited by this paper
• Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.

  2006cited by this paper
• Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

  2006cited by this paper
• Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia.

  2006cited by this paper
• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.

  2006cited by this paper
• Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.

  2006cited by this paper
• Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL.

  2005cited by this paper
• Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.

  2005cited by this paper
• Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease.

  2005cited by this paper
• Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study.

  2005cited by this paper
• Time-dependent associations between iron and mortality in hemodialysis patients.

  2005cited by this paper
• Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease.

  2005cited by this paper
• Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review.

  2005cited by this paper
• Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients.

  2004cited by this paper
• Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial.

  2004cited by this paper
• Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients.

  2004cited by this paper
• Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

  2004cited by this paper
• Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.

  2004cited by this paper
• A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients.

  2003cited by this paper
• Dialysis adequacy and response to erythropoietic agents: what is the evidence base?

  2003cited by this paper
• The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.

  2003cited by this paper
• Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients.

  2003cited by this paper
• Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Adjunctive therapy in anaemia management.

  2002cited by this paper
• Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994).

  2002cited by this paper
• Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life.

  2002cited by this paper
• Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients.

  2002cited by this paper
• Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients.

  2002cited by this paper
• Health care resource utilization and the impact of anemia management in patients with chronic kidney disease.

  2002cited by this paper
• Quality of life in end-stage renal disease patients.

  2001cited by this paper
• A randomized trial of iron deficiency testing strategies in hemodialysis patients.

  2001cited by this paper
• Ferritin and the response to oxidative stress.

  2001cited by this paper
• Erythropoietin and iron: the role of ascorbic acid.

  2001cited by this paper
• Suspected iron dextran-related adverse drug events in hemodialysis patients.

  2001cited by this paper
• Comprehensive Clinical Nephrology

  2000cited by this paper
• Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration.

  2000cited by this paper
• Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.

  2000cited by this paper
• Fluid state and blood pressure control in patients treated with long and short haemodialysis.

  1999cited by this paper
• Anemia and carnitine supplementation in hemodialyzed patients.

  1999cited by this paper
• Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.

  1999cited by this paper
• Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients.

  1998cited by this paper
• The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

  1998cited by this paper
• SUBCUTANEOUS COMPARED WITH INTRAVENOUS EPOETIN IN PATIENTS RECEIVING HEMODIALYSIS

  1998cited by this paper
• Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.

  1997cited by this paper
• The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis

  1997cited by this paper
• Long-term impact of recombinant human erythropoietin on transfusion support in patients with chronic renal failure

  1996cited by this paper
• L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin.

  1995cited by this paper
• Erythropoietin: oxygen-dependent control of erythropoiesis and its failure in renal disease.

  1994cited by this paper
• Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.

  1994cited by this paper
• Factors influencing anaemia in dialysis patients. A special survey by the EDTA-ERA Registry.

  1993cited by this paper
• Anemia of the regular hemodialysis patient and its treatment.

  1974cited by this paper
• Disorders of red blood cell production in uremia.

  1970cited by this paper

• Association Between the Vascular Ageing of the Carotid Arteries and Different Dialysis Modalities

  2025cites this paper
• The study of correlation of Selenium serum level with thyroid disorders in patients with end-stage renal disease in dialysis departments of Buali and Farhikhtegan Hospitals in 2022-2023

  2025cites this paper
• Association Between Telomere Shortening and Erythropoietin Resistance in Patients with Chronic Kidney Disease Undergoing Hemodialysis

  2025cites this paper
• Roxadustat enhances inflammation and metabolic reprogramming in human leukocytes by affecting oxygen sensing.

  2025cites this paper
• Hepcidin, GDF-15 and their Impact on Iron Metabolism in CKD

  2024cites this paper
• Prevalence and management of anemia and impact of treatment burden on health-related quality of life in chronic kidney disease and dialysis patients

  2024cites this paper
• Correlation between ultrafiltration rate and hemoglobin level and erythropoietin response in hemodialysis patients

  2024cites this paper
• Risk factors and current state of therapy for anemia after kidney transplantation

  2024cites this paper
• Anemia of Chronic Kidney Disease—A Narrative Review of Its Pathophysiology, Diagnosis, and Management

  2024influential citation
• Longitudinal evaluation of laboratory results and method precision in worldwide erythropoietin external quality assessments

  2024influential citation
• Admission Hemoglobin Associated with Increased Mortality in Hip Fracture Surgical Patients: An Observational Study

  2024cites this paper
• The association of hepcidin, reticulocyte hemoglobin equivalent and anemia-related indicators on anemia in chronic kidney disease

  2023cites this paper
• The application of artificial intelligence in the diagnosis and management of anemia

  2023cites this paper
• Markers of end-stage renal disease progression: beyond the GFR

  2023cites this paper
• Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study

  2023cites this paper
• The Role of L-Carnitine in Kidney Disease and Related Metabolic Dysfunctions

  2023cites this paper
• The association of apolipoprotein B with chronic kidney disease in the Chinese population

  2023cites this paper
• Haemoglobin response modelling under erythropoietin treatment: Physiological model‐informed machine learning method

  2023cites this paper
• Biomarkers of the End-Stage Renal Disease Progression: Beyond the GFR

  2023cites this paper
• CORRELATION BETWEEN THE PERCENTAGE OF HYPOCHROMIC ERYTHROCYTES AND FERRITINE LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING HEMODIALYSIS IN PKU BANTUL HOSPITAL

  2022cites this paper
• Magnitude of anemia and associated factors among adult patients at Baso Liben District: a cross-sectional study

  2022cites this paper
• Role of Serum Hepcidin Level in Predicting Anemia and Cardiovascular Morbidity in Children with Chronic Kidney Disease.

  2022cites this paper
• Efficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia

  2021cites this paper
• Pre-Frailty and Frailty in Dialysis and Pre-Dialysis Patients: A Systematic Review of Clinical and Biochemical Markers

  2021cites this paper
• Crosstalk of fibroblast growth factor 23 and anemia-related factors during the development and progression of CKD (Review).

  2021cites this paper
• The Impact of Intravenous Iron Supplementation on Hematinic Parameters and Erythropoietin Requirements in Hemodialysis Patients

  2021cites this paper
• Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial.

  2021cites this paper
• The Interplay Between Nutrition, Metabolic, and Endocrine Disorders in Chronic Kidney Disease.

  2021cites this paper
• Management of Anemia in Children Receiving Chronic Dialysis

  2021cites this paper
• Implementation of AdaBoost Algorithm in Prediction of Chronic Kidney Disease

  2021cites this paper
• Correlation between Hemoglobin Reticulocytes and Ferritin in Chronic Kidney Disease Patients Undergoing Hemodialysis at PKU Bantul

  2021cites this paper
• Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis

  2021cites this paper
• Clinical and genetic markers of erythropoietin deficiency anemia in chronic kidney disease (predialysis) patients.

  2020cites this paper
• Prevalensi dan komplikasi pada penderita gagal ginjal kronik yang menjalani hemodialisa di Rumah Sakit Umum Pusat Sanglah Denpasar tahun 2018

  2020cites this paper
• Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States.

  2020cites this paper
• Successful treatment of anti-EPO antibody associated refractory anemia with hypoxia-inducible factor prolyl hydroxylase inhibitor

  2020cites this paper
• Relationship between serum hepcidin levels and cardiovascular disease in patients with maintenance hemodialysis.

  2020cites this paper
• Does erythropoietin therapy affect circulating endothelial cells in hemodialysis patients?

  2020cites this paper
• Iron metabolism in patients with rheumatoid arthritis.

  2020cites this paper
• Differential Impacts of Intravenous Iron Administration and Iron-Containing Phosphate Binders on Serum Intact Fibroblast Growth Factor 23 Levels

  2019cites this paper
• Hepcidin in chronic kidney disease anemia.

  2019cites this paper
• Hemodialysis-Induced Anemia : Impact of a Nurse-Led Intervention on Health-Related Quality of Life

  2019cites this paper
• Relationship between hypertension with quality of life of hemodialysis patients.

  2019cites this paper
• DIAGNOSTIC VALUE OF RETICULOCYTE HEMOGLOBIN AND SOLUBLE TRANSFERRIN RECEPTOR IN DETERMINING THE IRON STATUS OF CHRONIC KIDNEY DISEASE WITH HEMODIALYSIS PATIENTS

  2019cites this paper
• Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF

  2019cites this paper
• Anästhesie bei Patienten mit Anämien, Polyzythämien und Methämoglobinämie

  2019cites this paper
• Comparing the effects of intravenous and subcutaneous Erythropoietin on blood indices in hemodialysis patients

  2019cites this paper
• Pathophysiological mechanisms of cardiovascular disease in chronic kidney disease and possibilities of prevention

  2019cites this paper
• Study of the Protective Effect of Nigella Sativa Oil on Tartrazine-Induced Hematological Disorders in Rats

  2019cites this paper
• Design, synthesis, and activity evaluation of novel erythropoietin mimetic peptides.

  2018cites this paper
• Perbedaan Profil Besi Pada Anemia Kronis Yang disebabkan Oleh Gagal Ginjal Kronis (GGK) di RSUD Dr.Moewardi.

  2018cites this paper
• Artificial Intelligence for the Artificial Kidney: Pointers to the Future of a Personalized Hemodialysis Therapy

  2018cites this paper
• Association of Freestanding Dialysis Facility Size, Quality Incentive Program Scores and Patient Survival

  2017cites this paper
• Concordance between Reticulocyte Hemoglobin Equivalent and Reticulocyte Hemoglobin Content in CKD Patients Undergoing Hemodialysis.

  2017cites this paper
• The HIF System Response to ESA Therapy in CKD‐Anemia

  2017cites this paper
• Anemia among hemodialysis patients; an updated mini-review

  2017cites this paper
• Chronic Kidney Disease in the Elderly

  2017cites this paper
• Oxidative stress in chronic dialysis patients.

  2017cites this paper
• Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD.

  2017cites this paper
• Erythropoietin: Endogenous Protection of Ischemic Brain.

  2017cites this paper
• V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

  2017cites this paper
• Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method

  2017cites this paper
• Efficacy and safety of subcutaneous administration of lyophilized powder of alfa-erythropoietin to maintain hemoglobin concentrations among hemodialysis patients

  2017cites this paper
• Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis

  2016cites this paper
• Anemia and high therapeutic doses of recombinant human erythropoietin in chronic kidney disease - a linkage of risk?

  2016cites this paper
• Can Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients?

  2016cites this paper
• STATUS NUTRISI PASIEN GAGAL GINJAL KRONIS DENGAN DIABETES MELLITUS DAN NON-DIABETES MELLITUS

  2016cites this paper
• Frequency of Specific Cardiovascular Disease Risk Factors among Cameroonian Patients on Dialysis: The Cases of Anaemia, Inflammation, Phosphate, and Calcium

  2016cites this paper
• Comparison of the effectiveness of equal doses of short and long-acting erythrocyte stimulating agents for managing anemia in chronic kidney disease adult patients

  2016cites this paper
• Factors Predicting Functional Status in End Stage Renal Disease Older Adults Receiving Hemodialysis

  2016cites this paper
• Contextualizando a Elevada Prevalência de Anemia na População Portuguesa: Perceção, Caracterização e Preditores: Um Sub-Estudo do EMPIRE

  2016cites this paper
• Iron deficiency anemia in pregnancy: controversies in iron supplementation

  2015cites this paper
• Anaemia in chronic obstructive pulmonary disease: an insight into its prevalence and pathophysiology.

  2015cites this paper
• Cardiovascular Risk Factors in Patients on Dialysis.

  2015cites this paper
• Efficacy and Safety of Methoxy Polyethylene Glycol Epoetin - Beta versus Epoetin Alpha for Treatment of Chronic Renal Anemia in Hemodialysis Patients

  2015influential citation
• Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia

  2015cites this paper
• Analisis Praktik Klinik Keperawatan pada Pasien Chronic Kidney Disease dengan Gangguan Rasa Cemas di Ruang Instalasi Gawat Darurat RSUD Abdul Wahab Sjahranie Samarinda Tahun 2015

  2015cites this paper
• Comparison of Efficacy of Continuous Erythropoietin Receptor Activator ( CERA ) in Chronic Kidney Disease Patients versus Patients on Hemodialysis : Single Center Experience

  2015cites this paper
• A new machine learning approach for predicting the response to anemia treatment in a large cohort of End Stage Renal Disease patients undergoing dialysis

  2015cites this paper
• Blood Transfusion, Serum Ferritin, and Iron in Hemodialysis Patients in Africa

  2015cites this paper
• Relação entre toxicidade urêmica, anemia e perda auditiva neurossensorial em indivíduos com doença renal crônica - um estudo prospectivo

  2014cites this paper
• Effect of erythropoietin on primed leucocyte expression profile

  2014cites this paper
• Anemia en enfermedad renal crónica

  2014cites this paper
• [New treatments of anemia in chronic renal failure].

  2014cites this paper
• Nuevos tratamientos de la anemia en la insuficiencia renal crónica

  2014cites this paper
• Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.

  2014cites this paper
• Mise en place d’une étude pilote, de faisabilité et d’évaluation du logiciel d’aide au diagnostic des anémies : Web-Anemia : étude réalisée en environnement réel, en soins primaires, chez 5 médecins généralistes de Haute-Normandie

  2014cites this paper
• ANALYSIS OF COST AND OUTCOME THERAPY OF BLOOD TRANSFUSION ON ANEMIA TREATMENT FOR INPATIENT WITH CHRONIC RENAL FAILURE

  2014influential citation
• Human cytomegalovirus inhibits erythropoietin production.

  2014cites this paper
• Hepcidin levels in chronic hemodialysis patients: a critical evaluation

  2014cites this paper
• THz frequency generation using Gaussian pulse for medical applications

  2013cites this paper
• Management of Anemia on Hemodialysis

  2013cites this paper
• Hematologic manifestations of kidney disease.

  2013cites this paper
• Clinical and economic evaluation of an evidence-based institutional epoetin-utilization management program.

  2013cites this paper
• Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide

  2013cites this paper
• Biomarkers of Hypochromia: The Contemporary Assessment of Iron Status and Erythropoiesis

  2013cites this paper
• Iron deficiency anaemia in chronic kidney disease.

  2013cites this paper
• Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease.

  2012cites this paper
• Decisive Indicator for Gastrointestinal Workup in Anemic Patients with Nondialysis Chronic Kidney Disease

  2012cites this paper
• Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis

  2012cites this paper